[
  {
    "ts": null,
    "headline": "Baird Maintains Outperform on Labcorp Hldgs, Raises Price Target to $326",
    "summary": "Baird  analyst Eric Coldwell   maintains Labcorp Hldgs (NYSE:LH) with a Outperform and raises the price target from $313 to $326.",
    "url": "https://finnhub.io/api/news?id=1cdd1e59f7e7b0ff0e7642deb2c0b59f0d6c16415796d7ef181487f2d626b21c",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771405535,
      "headline": "Baird Maintains Outperform on Labcorp Hldgs, Raises Price Target to $326",
      "id": 139136046,
      "image": "",
      "related": "LH",
      "source": "Benzinga",
      "summary": "Baird  analyst Eric Coldwell   maintains Labcorp Hldgs (NYSE:LH) with a Outperform and raises the price target from $313 to $326.",
      "url": "https://finnhub.io/api/news?id=1cdd1e59f7e7b0ff0e7642deb2c0b59f0d6c16415796d7ef181487f2d626b21c"
    }
  },
  {
    "ts": null,
    "headline": "LH Q4 Deep Dive: Specialty Testing and Hospital Partnerships Offset Volume Challenges",
    "summary": "Healthcare diagnostics company Labcorp Holdings (NYSE:LH) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 5.6% year on year to $3.52 billion. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $14.7 billion at the midpoint. Its non-GAAP profit of $4.07 per share was 3.2% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=ca819d46d058ba72326e10b24e6ed501570d4f479f8e30c24656d8400af463cb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771392735,
      "headline": "LH Q4 Deep Dive: Specialty Testing and Hospital Partnerships Offset Volume Challenges",
      "id": 139132834,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Healthcare diagnostics company Labcorp Holdings (NYSE:LH) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 5.6% year on year to $3.52 billion. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $14.7 billion at the midpoint. Its non-GAAP profit of $4.07 per share was 3.2% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=ca819d46d058ba72326e10b24e6ed501570d4f479f8e30c24656d8400af463cb"
    }
  },
  {
    "ts": null,
    "headline": "Labcorp Holdings Inc. Q4 2025 Earnings Call Summary",
    "summary": "Moby summary of Labcorp Holdings Inc.'s Q4 2025 earnings call",
    "url": "https://finnhub.io/api/news?id=d3e0a97a59db3320d64533cb66e75d79428233e1b61027106a18ce29bba0ed68",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771376781,
      "headline": "Labcorp Holdings Inc. Q4 2025 Earnings Call Summary",
      "id": 139134432,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Moby summary of Labcorp Holdings Inc.'s Q4 2025 earnings call",
      "url": "https://finnhub.io/api/news?id=d3e0a97a59db3320d64533cb66e75d79428233e1b61027106a18ce29bba0ed68"
    }
  }
]